Other languages Valneva Xetra

Equities

Market Closed - Xetra Other stock markets 09:05:37 31/05/2024 pm IST			5-day change	1st Jan Change
4.112 ^EUR	+2.24%		+5.33%	-13.41%

31/05	Valneva's Chikungunya Vaccine Gains Support From EU Regulator Committee	MT
31/05	EU regulator recommends use of Valneva's chikungunya vaccine	RE

Valneva's Chikungunya Vaccine Gains Support From EU Regulator Committee	31/05
Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine	31/05
Valneva Receives EMA’s Positive CHMP Opinion for its Chikungunya Vaccine	31/05
EU regulator recommends use of Valneva's chikungunya vaccine	31/05
Valneva Se Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer	22/05
Valneva Names New Chief Scientific Officer	21/05
Valneva : nomination d'un directeur scientifique	21/05
Valneva Appoints Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer	21/05
Valneva : nouvelles données positives dans le CHIKV	13/05
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine	13/05
Valneva Reports Further Positive Pivotal Phase 3 Data in Adolescents for its Single-Shot Chikungunya Vaccine	13/05
Valneva SE Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05
Transcript : Valneva SE, Q1 2024 Earnings Call, May 07, 2024	07/05
Valneva : trimestriels dopés par la vente du PRV	07/05
Valneva : Q1 2024 Financial Results	07/05
Valneva : Reports First Quarter 2024 Financial Results and Provides Corporate Updates	07/05
Valneva Reports First Quarter 2024 Financial Results and Provides Corporate Updates	07/05
Valneva SE Confirms Earnings Guidance for the Fiscal Year 2024	07/05
Valneva : Document AMF CP. 2024E960493	16/04
Valneva : Deep Track Biotechnology Master détient moins de 5%	11/04

No results for this search